|
Market Closed -
Sao Paulo
15:45:40 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 920.26 BRL | +4.26% |
|
-3.87% | +41.46% |
| 10-20 | Dialysis Providers Under Pressure - U.S. Kidney Care Plan | DP |
| 10-15 | Davita Brings New Clinical Research to Asn Kidney Week, Advancing Evidence for the Next Era of Kidney Care | CI |
| Market Cap | 11.71B 58.99B 10.46B 9.66B 8.76B 16.38B 1,112B 16.65B 116B 46.03B 582B 43.95B 43.02B 1,836B | P/E 2026 * |
12.6x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 22.53B 114B 20.12B 18.59B 16.85B 31.52B 2,139B 32.04B 224B 88.57B 1,121B 84.57B 82.77B 3,534B | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 1.54x |
| Free-Float |
49.06% | Yield 2026 * |
0.91% | Yield 2027 * | 0.91% |
Last Transcript: DaVita Inc.
| 1 day | +4.26% | ||
| 1 week | -3.87% | ||
| Current month | +0.82% | ||
| 1 month | +1.28% | ||
| 3 months | -23.66% | ||
| 6 months | +21.02% | ||
| Current year | +41.46% |
| 1 week | 862 |  | 930.6 |
| 1 month | 862 | | 958.23 |
| Current year | 546.63 | | 1,253.26 |
| 1 year | 546.63 | | 1,253.26 |
| 3 years | 382.2 | | 1,253.26 |
| 5 years | 341.13 | | 1,253.26 |
| 10 years | 171.72 | | 1,253.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 65 | 2019-05-31 |
Joel Ackerman
DFI | Director of Finance/CFO | 61 | 2017-02-26 |
David Maughan
COO | Chief Operating Officer | 49 | 2024-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 72 | 2020-05-31 |
Barbara Desoer
BRD | Director/Board Member | 73 | 2015-10-07 |
Javier Rodriguez
BRD | Director/Board Member | 65 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.26% | -3.87% | - | - | 11.71B | |
| -1.07% | +1.20% | +14.09% | +35.52% | 120B | |
| +0.37% | +2.22% | +4.92% | +103.82% | 102B | |
| +0.64% | +2.67% | +109.83% | +890.32% | 58.23B | |
| +1.75% | +2.27% | -5.92% | +83.08% | 29.08B | |
| -0.57% | +2.93% | +32.78% | +95.74% | 26.61B | |
| -0.30% | +3.46% | +17.70% | +65.59% | 26.68B | |
| -0.81% | +0.45% | +27.60% | +378.95% | 21.62B | |
| +1.48% | -4.31% | -22.04% | -5.67% | 19.58B | |
| -0.68% | +2.72% | +3.48% | +85.69% | 18.93B | |
| Average | +0.51% | +0.91% | +20.27% | +192.56% | 46.87B | |
| Weighted average by Cap. | +0.05% | +1.64% | +23.67% | +196.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.16B 71.32B 12.64B 11.68B 10.58B 19.8B 1,344B 20.13B 141B 55.64B 704B 53.13B 52B 2,220B | 14.64B 73.74B 13.07B 12.08B 10.94B 20.47B 1,390B 20.81B 145B 57.53B 728B 54.94B 53.77B 2,295B |
| Net income | 940M 4.73B 839M 775M 703M 1.31B 89.21B 1.34B 9.33B 3.69B 46.74B 3.53B 3.45B 147B | 1.01B 5.09B 901M 833M 755M 1.41B 95.83B 1.44B 10.02B 3.97B 50.21B 3.79B 3.71B 158B |
| Net Debt | 10.82B 54.52B 9.67B 8.93B 8.09B 15.14B 1,027B 15.39B 107B 42.54B 538B 40.62B 39.76B 1,697B | 10.8B 54.41B 9.65B 8.91B 8.08B 15.11B 1,025B 15.36B 107B 42.45B 537B 40.54B 39.67B 1,694B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | R$920.26 | +4.26% | 6 |
| 26-10-21 | R$882.64 | +0.41% | 9 |
| 26-10-20 | R$879.00 | -8.18% | 106 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DVA Stock
- DVAI34 Stock
Select your edition
All financial news and data tailored to specific country editions
